30% Off | Aarkstore.in || Pricing and reimbursement of the healthcare system in india

1. You can also request for sample page of above
mention reports on sample@aarkstore.com

2. Published Date : 31 March 2012
Pages : 57
PDF - $ 3500 | Site Licence - $ 7000 $ | Enterprise License - $
10500 | Discounted price - $ 2450
Company announces 30% discount on this report.
Discount till 30th Nov. 2012

3. Summary
Company, the leading business intelligence provider, has released its latest
research Pricing and Reimbursement of the Healthcare System in India - Low
Levels of Drug Reimbursement Lead to a High Out-Of-Pocket Expenditure”. It
provides a comprehensive overview of the healthcare system, and pricing and
reimbursement process in India with a detailed analysis of the different
regulatory mechanisms used in India. The report closely scrutinizes the major
changes in pharmaceuticals related pricing and reimbursement in the recent
past, and the impact these changes will have in the future. The health insurance
is responsible for facilitating demand by making high-cost prescription drugs
more affordable. Although the per capita income is rising in India, the modest
income of most of the population keeps the high cost drugs and medicines out of
reach of the majority of the population. Drugs would become more expensive
with the enforcement of product patents and so the sales of the expensive drugs
depend on the growth and the maturity of the health insurance sector. If the
health insurance industry does not mature, the market for patented drugs
would experience adverse effects. The next three to five years will see a
significant growth and change in the Indian health insurance industry as new
insurance players and insurance products respond to the increased demand.

4. Scope
- Detailed study of the healthcare systems and roles of the key insurance players in
the drug reimbursement process
- Analysis of the major pricing and reimbursement mechanisms in India.
- Key trends that follow from the recent changes brought about in the pricing and
reimbursement mechanism.
- Build an understanding of the possible major challenges brought about by the
enactment of changes in the pricing and reimbursement scene in India.
Reasons to buy
- Build understanding of the pharmaceuticals related key pricing and reimbursement
mechanisms in India and also specifically in some states of India.
- Optimize your investment through the identification and understanding of the
changes in the pharmaceuticals regulatory mechanism in the Indian economy.
- Develop effective business strategies related to new drug launches through the
analytical insight gained from key trends in the pricing and reimbursement scene of
India.

5. Table of Contents :
1.1 List of Tables 5
1.2 List of Figures 5
2 Pricing and Reimbursement in India - Introduction 6
2.1 GBI Research Report Guidance 6
3 Pricing and Reimbursement in India - Overview 7
3.1 Introduction to Healthcare System in India 7
3.1.1 Healthcare Expenditure Highly Correlated with GDP 7
3.1.2 Estimated Public Health Spending as a Percentage of GDP 9
3.1.3 Health Expenditure per Capita 9
3.1.4 Out-of-Pocket Health Expenditure as a Percentage of Private
Expenditure on Health 10
3.1.5 Demographics by Age 10
3.2 Public Healthcare System 11
3.2.1 Drug Distribution in the Public Sector 12
3.3 Private Healthcare System 12
3.4 Rationale for Drug Use in the Healthcare Facilities 13………..

6. More Discounted Reports:
Pricing and Reimbursement of the Healthcare System in India - Low
Levels of Drug Reimbursement Lead to a High Out-Of-Pocket
Expenditure
Pharmaceutical Pricing and Reimbursement in China - Series of
Mandated Price Cuts Not Effective in Stemming Healthcare
Expenditures
Pricing and Reimbursement in Brazil - Health Technology Assessment
(HTA) Studies to Facilitate Setting of Ceiling Prices for New Drugs
Pricing and Reimbursement in Russia - Big Pharma Take Advantage of
Reimbursement for Costly Drugs Through the DLO’s Seven Nosologies
Program
Pricing and Reimbursement in the US - Non-LIS Beneficiaries Not
Covered by Medicare Coverage Gap to Gain from Reduction in Out-of-
Pocket Expenditure for Generic Drugs

7. For More details about above & other Reports
plz contact :
Lavanya
Aarkstore.com
Contact: Marketing team
Mob.No.918149852585
Email: enquiry@aarkstore.com ,
discount@aarkstore.com
URL: http://www.aarkstore.com
http://in.linkedin.com/in/aarkstore
http://www.facebook.com/aarkstore